Dengue

A new vaccine targeting mosquito saliva proteins proved safe and prompted a strong immune response in humans, moving scientists one step closer to halting the transmission of all mosquito-borne pathogens.

Researchers employ CRISPR technology in a variety of creative ways to control the spread of vector-borne illnesses.